MovDisordV3, PubMed, Curation, bibRecord, 003424

Reversible orofacial dyskinesia after ofloxacin treatment.

Identifieur interne : 003424 ( PubMed/Curation ); précédent : 003423; suivant : 003425

Reversible orofacial dyskinesia after ofloxacin treatment.

Auteurs : Jan L. De Bleecker [Belgique] ; Veerle L. Vervaet ; Angela De Sarro

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2004.

RBID : pubmed:15197723

English descriptors

KwdEn :
- Adult, Anti-Infective Agents (adverse effects), Anti-Infective Agents (therapeutic use), Antiparkinson Agents (therapeutic use), Biperiden (therapeutic use), Dyskinesia, Drug-Induced (drug therapy), Dyskinesia, Drug-Induced (etiology), Humans, Male, Respiratory Tract Infections (drug therapy).
MESH :
- chemical , adverse effects : Anti-Infective Agents.
- chemical , therapeutic use : Anti-Infective Agents, Antiparkinson Agents, Biperiden.
- drug therapy : Dyskinesia, Drug-Induced, Respiratory Tract Infections.
- etiology : Dyskinesia, Drug-Induced.
- Adult, Humans, Male.

Abstract

We report on a patient who developed orofacial dyskinesia 3 days after starting ofloxacin treatment. The association of orofacial dyskinesia with other fluoroquinolone antibiotics has been reported rarely, chiefly in the elderly with impaired renal or hepatic function or in overdosed patients. It has been ascribed to interference with GABA-ergic neurotransmission.

DOI: 10.1002/mds.20053
PubMed: 15197723

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003424

Links to Exploration step

pubmed:15197723

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reversible orofacial dyskinesia after ofloxacin treatment.</title>
<author><name sortKey="De Bleecker, Jan L" sort="De Bleecker, Jan L" uniqKey="De Bleecker J" first="Jan L" last="De Bleecker">Jan L. De Bleecker</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Gent University Hospital, Ghent, Belgium. ja.debleeker@ugent.be</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Neurology, Gent University Hospital, Ghent</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vervaet, Veerle L" sort="Vervaet, Veerle L" uniqKey="Vervaet V" first="Veerle L" last="Vervaet">Veerle L. Vervaet</name>
</author>
<author><name sortKey="De Sarro, Angela" sort="De Sarro, Angela" uniqKey="De Sarro A" first="Angela" last="De Sarro">Angela De Sarro</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15197723</idno>
<idno type="pmid">15197723</idno>
<idno type="doi">10.1002/mds.20053</idno>
<idno type="wicri:Area/PubMed/Corpus">003424</idno>
<idno type="wicri:Area/PubMed/Curation">003424</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Reversible orofacial dyskinesia after ofloxacin treatment.</title>
<author><name sortKey="De Bleecker, Jan L" sort="De Bleecker, Jan L" uniqKey="De Bleecker J" first="Jan L" last="De Bleecker">Jan L. De Bleecker</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Gent University Hospital, Ghent, Belgium. ja.debleeker@ugent.be</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Neurology, Gent University Hospital, Ghent</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vervaet, Veerle L" sort="Vervaet, Veerle L" uniqKey="Vervaet V" first="Veerle L" last="Vervaet">Veerle L. Vervaet</name>
</author>
<author><name sortKey="De Sarro, Angela" sort="De Sarro, Angela" uniqKey="De Sarro A" first="Angela" last="De Sarro">Angela De Sarro</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anti-Infective Agents (adverse effects)</term>
<term>Anti-Infective Agents (therapeutic use)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Biperiden (therapeutic use)</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Humans</term>
<term>Male</term>
<term>Respiratory Tract Infections (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Infective Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Infective Agents</term>
<term>Antiparkinson Agents</term>
<term>Biperiden</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on a patient who developed orofacial dyskinesia 3 days after starting ofloxacin treatment. The association of orofacial dyskinesia with other fluoroquinolone antibiotics has been reported rarely, chiefly in the elderly with impaired renal or hepatic function or in overdosed patients. It has been ascribed to interference with GABA-ergic neurotransmission.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">15197723</PMID>
<DateCreated><Year>2004</Year>
<Month>06</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted><Year>2004</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>19</Volume>
<Issue>6</Issue>
<PubDate><Year>2004</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Reversible orofacial dyskinesia after ofloxacin treatment.</ArticleTitle>
<Pagination><MedlinePgn>731-2</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We report on a patient who developed orofacial dyskinesia 3 days after starting ofloxacin treatment. The association of orofacial dyskinesia with other fluoroquinolone antibiotics has been reported rarely, chiefly in the elderly with impaired renal or hepatic function or in overdosed patients. It has been ascribed to interference with GABA-ergic neurotransmission.</AbstractText>
<CopyrightInformation>Copyright 2004 Movement Disorder Society</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Bleecker</LastName>
<ForeName>Jan L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Gent University Hospital, Ghent, Belgium. ja.debleeker@ugent.be</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vervaet</LastName>
<ForeName>Veerle L</ForeName>
<Initials>VL</Initials>
</Author>
<Author ValidYN="Y"><LastName>De Sarro</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0FRP6G56LD</RegistryNumber>
<NameOfSubstance UI="D001712">Biperiden</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000890">Anti-Infective Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001712">Biperiden</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004409">Dyskinesia, Drug-Induced</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012141">Respiratory Tract Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>6</Month>
<Day>16</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>6</Month>
<Day>16</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15197723</ArticleId>
<ArticleId IdType="doi">10.1002/mds.20053</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003424 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003424 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:15197723
   |texte=   Reversible orofacial dyskinesia after ofloxacin treatment.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:15197723" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Reversible orofacial dyskinesia after ofloxacin treatment.

Reversible orofacial dyskinesia after ofloxacin treatment.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki